Torrent Pharmaceuticals Ltd (GREY:TQRRY)
$ 0 0 (0%) Market Cap: - Enterprise Value: 4.56 Bil PE Ratio: 60.09 PB Ratio: 14.43 GF Score: 94/100

Q1 2024 Torrent Pharmaceuticals Ltd Earnings Call Transcript

Aug 07, 2023 / 12:30PM GMT
Operator

Ladies and gentlemen, good day, and welcome to the Q1 FY '24 Earnings Conference Call of Torrent Pharmaceuticals. (Operator Instructions) Please note that this conference is being recorded. I would now like to hand the conference over to Mr. Sudhir Menon, Chief Financial Officer and Executive Director. Thank you, and over to you, sir.

Sudhir Menon
Torrent Pharmaceuticals Limited - Executive Director of Finance & CFO

Thank you. Good evening, and welcome to Quarter 1 FY '24 Earnings Call of Torrent. While we see -- while we continue to see strong underlying market beating growth in our branded business. On the generic side, Germany has registered a sequential increase in the revenues on the back of tender wins in the last 3 quarters, while the U.S. business has delivered stable revenues for the quarter.

In terms of key financial performance indicators for quarter 1, revenues were INR 2,591 crores, up by 10% compared to the previous year same quarter. Operating EBITDA for the quarter is INR 791 crores. Operating EBITDA margin stands at 30.5% and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot